BioSpace News Archive

Press Releases

Ginkgo Bioworks Reports First Quarter 2025 Financial Results

May 7, 2025
·
18 min read
Press Releases

Adcentrx Therapeutics Granted Fast Track Designation for ADRX-0706 Nectin-4 ADC for the Treatment of Advanced Cervical Cancer

May 7, 2025
·
4 min read
Press Releases

CStone Presents Preclinical Results of CS2011 (EGFR/HER3 bispecific antibody), CS5007 (EGFR/HER3 bispecific ADC), CS5005 (SSTR2 ADC) and CS5006 (ITGB4 ADC) at 2025 AACR

May 7, 2025
·
10 min read
Press Releases

Novo Nordisk’s sales increased by 19% in Danish kroner and by 18% at constant exchange rates to DKK 78.1 billion in the first three months of 2025

May 7, 2025
·
3 min read
Press Releases

Evotec Receives $ 2.5 m Grant to Generate Next Generation Tuberculosis Treatments

May 7, 2025
·
4 min read
Press Releases

Dr. Falk Pharma announces positive results from its pivotal phase 3 trial on norucholic acid in primary sclerosing cholangitis

May 7, 2025
·
5 min read
Press Releases

The world’s first: Grand Pharma’s global innovative product STC3141 successfully reached the clinical endpoint in the Phase II clinical study in China

May 7, 2025
·
6 min read
Press Releases

Gilead’s Livdelzi® (Seladelpar) Demonstrated Consistent Efficacy and Safety Regardless of Prior Treatment History in New Data Presented at EASL 2025

May 7, 2025
·
14 min read
Press Releases

Yaqrit’s HE candidates set for phase 3 as company shows underpinning data at EASL

May 7, 2025
·
4 min read
Press Releases

Final Data From the Phase 3 MYR301 Study Demonstrated Longer Treatment With Bulevirtide Was Associated With Sustaining Undetectability After Stopping Treatment

May 7, 2025
·
7 min read